- Home
- GRBK vs PTGX Comparison
GRBK vs PTGX Comparison
Compare GRBK & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRBK
- PTGX
- Stock Information
- Founded
- GRBK 2006
- PTGX 2006
- Country
- GRBK United States
- PTGX United States
- Employees
- GRBK N/A
- PTGX N/A
- Industry
- GRBK Homebuilding
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- GRBK Consumer Discretionary
- PTGX Health Care
- Exchange
- GRBK Nasdaq
- PTGX Nasdaq
- Market Cap
- GRBK 2.7B
- PTGX 2.7B
- IPO Year
- GRBK N/A
- PTGX 2016
- Fundamental
- Price
- GRBK $59.84
- PTGX $36.82
- Analyst Decision
- GRBK Hold
- PTGX Strong Buy
- Analyst Count
- GRBK 3
- PTGX 8
- Target Price
- GRBK $65.50
- PTGX $54.63
- AVG Volume (30 Days)
- GRBK 327.9K
- PTGX 660.4K
- Earning Date
- GRBK 02-27-2025
- PTGX 02-25-2025
- Dividend Yield
- GRBK N/A
- PTGX N/A
- EPS Growth
- GRBK 34.39
- PTGX N/A
- EPS
- GRBK 7.71
- PTGX 2.68
- Revenue
- GRBK $1,982,011,000.00
- PTGX $323,795,000.00
- Revenue This Year
- GRBK $19.54
- PTGX $441.08
- Revenue Next Year
- GRBK $9.88
- PTGX N/A
- P/E Ratio
- GRBK $7.77
- PTGX $13.72
- Revenue Growth
- GRBK 12.72
- PTGX 125.73
- 52 Week Low
- GRBK $48.66
- PTGX $23.89
- 52 Week High
- GRBK $84.66
- PTGX $48.89
- Technical
- Relative Strength Index (RSI)
- GRBK 49.86
- PTGX 39.62
- Support Level
- GRBK $58.83
- PTGX $35.03
- Resistance Level
- GRBK $61.19
- PTGX $40.07
- Average True Range (ATR)
- GRBK 1.60
- PTGX 1.56
- MACD
- GRBK 1.00
- PTGX -0.04
- Stochastic Oscillator
- GRBK 79.28
- PTGX 34.89
About GRBK Green Brick Partners Inc.
Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgage and title, through its subsidiaries.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.